Latest News and Press Releases
Want to stay updated on the latest news?
-
Press release Regulated information Brussels, April 3, 2026, 17:45 CEST In line with Belgian transparency legislation (Law of May 2,...
-
Persbericht Gereglementeerde informatie Brussel, 3 april 2026 - 17u45 CEST In overeenstemming met de Belgische transparantiewetgeving (Wet...
-
Communiqué de presse Information réglementée Bruxelles, le 3 avril 2026 - 17h45 CEST Conformément à la législation et réglementation en...
-
HOUSTON, April 02, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) (NASDAQ: HMH) today announced the closing of its initial public offering of 10,520,000 shares of its Class A common stock at...
-
TORONTO, April 01, 2026 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp., is pleased to...
-
HOUSTON, March 31, 2026 (GLOBE NEWSWIRE) -- HMH Holding Inc. (“HMH”) today announced the pricing of its initial public offering of 10,520,000 shares of its Class A common stock at $20.00 per share....
-
GREELEY, Colo., March 30, 2026 (GLOBE NEWSWIRE) -- JBS USA Food Company Holdings announced today the commencement of tender offers (the “Tender Offers”) to purchase for cash a combined aggregate...
-
WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to...
-
WALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to...
-
Positive interim Phase 1 data for BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor, demonstrating potential best-in-class reductions in...